The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2019
DOI: 10.1056/nejmoa1805101
|View full text |Cite
|
Sign up to set email alerts
|

Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

13
378
2
14

Year Published

2019
2019
2021
2021

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 549 publications
(457 citation statements)
references
References 26 publications
13
378
2
14
Order By: Relevance
“…Attrition during neoadjuvant therapy was significant compared with that in clinical trials, but similar to that of previous consecutive cohort data. Although three RCTs have reported reduced pulmonary morbidity with minimally invasive approaches, all patients in the present study underwent open surgery, so the implications for minimally invasive oesophagectomy are unclear. However, the present data provide a useful framework for further research in this context.…”
Section: Discussionsupporting
confidence: 84%
See 1 more Smart Citation
“…Attrition during neoadjuvant therapy was significant compared with that in clinical trials, but similar to that of previous consecutive cohort data. Although three RCTs have reported reduced pulmonary morbidity with minimally invasive approaches, all patients in the present study underwent open surgery, so the implications for minimally invasive oesophagectomy are unclear. However, the present data provide a useful framework for further research in this context.…”
Section: Discussionsupporting
confidence: 84%
“…A transhiatal approach has been suggested for patients with significant pulmonary co‐morbidity, owing to a reduced incidence of postoperative pulmonary complications and because the need for single‐lung ventilation in obviated, and the present data may inform such discussions. However, minimally invasive approaches may produce similar benefits for patients with significant baseline pulmonary co‐morbidity, while producing favourable oncological outcomes even compared with open transthoracic resection.…”
Section: Discussionmentioning
confidence: 99%
“…A total of 24 studies with 7117 patients were involved in the analysis of all‐cause RCs. Figure a shows that the patients who underwent MIE experienced less postoperative RCs as compared to those who underwent OE (OR = 0.56; 95% CI = 0.41, 0.78; P = <0.001).…”
Section: Resultsmentioning
confidence: 99%
“…A total of 22 studies with 6925 patients were included in the analysis of all‐cause AL, which showed low level of heterogeneity ( P = 0.08, I 2 = 32%) and no statistical difference between MIE versus OE (OR = 1.08; 95% CI = 0.92, 1.26; P = 0.35) (Figs b, S2c). Data for all‐cause CCs was reported in 13 studies with 2302 patients and showed neither heterogeneity ( P = 0.99, I 2 = 0%), nor statistically significant difference between MIE or OE (OR = 0.97; 95% CI = 0.74, 1.26; P = 0.81) (Figs a, S2d).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation